Filter Results:
(177)
Show Results For
- All HBS Web
(177)
- News (50)
- Research (89)
- Events (2)
- Multimedia (3)
- Faculty Publications (47)
Show Results For
- All HBS Web
(177)
- News (50)
- Research (89)
- Events (2)
- Multimedia (3)
- Faculty Publications (47)
- 14 Apr 2014
- News
The Puzzle of Life
capitalize companies that may not make sense for venture funds but do make sense for smart angels who have more patience than most VCs." Among those companies: Rani Therapeutics, an early-stage venture focused on making injectable View Details
- 01 Mar 2019
- News
The Blue-Green Revolution
the single-celled organisms to bulk up on fat like bears preparing for winter. Alas, just like bears, the microscopic butterballs eventually go into hibernation. And once that happens, they stop growing, negating the gains made in oil production. SGI solved that View Details
- 15 Apr 2014
- News
Bertarelli Foundation Gift Names Deans' Health & Life Sciences Challenge Prize
served on the HMS Biological Chemistry and Molecular Pharmacology (BCMP) Council from 2000-2003. He is a member of the Strategic Advisory Board at Ecole Polytechnique Fédérale de Lausanne [EPFL] in Switzerland. The Bertarelli Foundation... View Details
- 14 Jul 2015
- First Look
First Look: July 14, 2015
In press Journal of Experimental Psychology: General Hormones and Ethics: Understanding the Biological Basis of Unethical Conduct By: Lee, Jooa Julia, Francesca Gino, Ellie Shuo Jin, Leslie K. Rice, and Robert A. Josephs... View Details
Keywords: Sean Silverthorne
- 27 Feb 2024
- Blog Post
Fighting Cancer with a Novel Cell Therapy: Ananya Zutshi (MS/MBA '21)
Professor of Biologically Inspired Engineering, and David Mooney, Robert P. Pinkas Family Professor of Bioengineering. After finishing her degree, she stayed at Harvard for another year as an HBS Blavatnik Fellow in Life Science... View Details
- 21 Mar 2019
- Blog Post
What I Didn't Know About HBS Faculty
Khalid Alghimlas earned his bachelor’s degree in chemical and biological engineering from Colorado State University in 2011 and is a strategist and business development consultant. Khalid was born and raised in the eastern province of... View Details
- 27 Apr 2023
- News
Life Preserver
When Sebastian Giwa (MBA 2009) joined Singularity University's Global Solutions Program in the summer of 2012, he was accepted based on his ideas of how distance learning and remote work—both rarities at that point—could reshape opportunities for youth in developing... View Details
Keywords: April White
- 28 Feb 2011
- News
Rebooting the Human Condition
engineered cells, biological tissue, and robots. This perfect storm of innovation will allow humans to shape their own evolution (as well as that of other species) and create solutions to energy, health, and economic problems. Enriquez... View Details
- 31 May 2011
- First Look
First Look: May 31
confident of the market potential for mobile payments, they recognized the challenges they faced in scaling their current business model. Purchase this case:http://cb.hbsp.harvard.edu/cb/product/811029-PDF-ENG Office of Technology Transfer—Shanghai Institutes for View Details
Keywords: Sean Silverthorne
- 10 Aug 2020
- Research & Ideas
COVID's Surprising Toll on Careers of Women Scientists
timed experiments—like biological and chemical fields—research time slid 30 to 40 percent. Overall, 55 percent of the respondents reported a decline in total work hours, 27 percent indicated no change, and 18 percent said they were... View Details
- 15 Sep 2020
- Blog Post
One Month into the New MS/MBA Biotech
Alberts et al. Thus, to answer your question, it’s possible that a non-science major may be prepared if they have the necessary course background in molecular and cellular biology, whereby a student who majored in a biological science... View Details
- 06 Dec 2018
- News
Source Code
surroundings, and learning as we go. That’s biological intelligence. But artificial intelligence—at least the way that it’s currently constructed—doesn’t work this way. Let’s use Google as an example. HEAR MORE Listen to Donna Dubinsky... View Details
- 11 Sep 2007
- First Look
First Look: September 11, 2007
developing proven molecules from strategic partners to leapfrog competition and create large molecule biologics in India. The company understood that its transition from an API to an innovation-led company focused on new View Details
Keywords: Martha Lagace
- Profile
Hunter Goble
scientists in Harvard and MIT’s ecosystem. Through a self-matching process that Hunter describes as “speed dating,” he found two scientists from Boston’s Children’s Hospital developing “a novel drug delivery platform that increases the absorption of View Details
- 09 Aug 2016
- First Look
August 9, 2016
drugs that have been shown to be therapeutically equivalent to an already approved original biologic drug—have only been approved in the United States since 2015. Europe has had biosimilar entry since 2006. This paper considers how... View Details
Keywords: Sean Silverthorne
- 18 Jul 2024
- Blog Post
Harvard Business School Announces Its 2024-2025 Blavatnik Fellows
startup aiming to make biologics more accessible to patients worldwide. Sanso was created to commercialize the microporous water technology out of Jarad Mason's lab at Harvard, a novel solution to dramatically increase the oxygen capacity... View Details
- 30 Sep 2019
- Book
Book Excerpt: Why a Volume on Race, Work, and Leadership
construction of blackness has been an economic tool for centuries; it has been used as a means of sourcing under- or wholly unpaid labor, rationalized by an attribution of blacks’ biological inferiority. Though research has since amassed... View Details
- 31 Oct 2023
- Blog Post
Climate Change Pioneers in the Class of 1978
faculty chair of the HBS Business and Environment Initiative, Grace Chao (Section A) organized the panel. Our three alumni discussed their pioneering activities: Steve Kahn (Section A) is the co-founder and executive chairman of NewLeaf Symbiotics, an agricultural... View Details
- 01 Feb 2000
- News
The Future Is Now: 21st-Century Business Pondered at HBS Forum
there will be entities that claim they are human because they will be copies of human thinking." As humans, he said, "we will put devices in our own brains to expand our own thinking so there will be a real merger of biological and... View Details
- 06 Jun 2017
- First Look
First Look at New Research and Ideas: June 6, 2017
Pharmacyclics is a biotechnology company that had received FDA approval in late 2013 for its flagship asset Imbrivica (ibrutinib), a biologic treatment for chronic lymphocytic leukemia and two other even rarer blood malignancies. Entering... View Details
Keywords: Sean Silverthorne